Archive for the ‘Commentary’ Category

New to tissue engineering and/or neural stem cells? This review & textbook are for you!

Author: Guest, 09/20/17

Samantha is a PhD Candidate studying neural stem cell biology in Dr. Derek van der Kooy’s lab at the University of Toronto. Her research focuses on neural stem cell hierarchies in the developing mammalian brain, and activation of quiescent stem cells in the adult brain. She is also an avid science communicator on social media…Read more

‘Bad Luck 2.0’ – the transformation to success

Author: Sara M. Nolte, 09/12/17

Over two years ago, an article published in Science took the Internet and media by storm. The paper, “Variation in cancer risk among tissues can be explained by the number of stem cell divisions,” better known as “The ‘Bad Luck’ Cancer Study,” used mathematical modeling to demonstrate that most cancers were a result of chance…Read more

Right Turn: Why #ILookLikeAnEngineer is still around

Author: Stacey Johnson, 09/08/17

  I was on a Toronto subway this week and saw a woman wearing a button with #ILookLikeAnEngineer (see image right). Having blogged about this topic myself in 2015 and also having featured the blog of a female engineer sharing her thoughts, I was pleased to see this important campaign had jumped over to the…Read more

Right Turn: Teaching kids critical thinking skills

Author: Stacey Johnson, 09/01/17

I love kids. Their curiosity, passion and enthusiasm for life are infectious. With two teenagers at home, kids and school are very much on my mind right now. (I have a habit of blogging about back-to-school, as you can read here and here.) Because kids are so curious, they constantly explore the world around them….Read more

Trying to get it right: a blog carnival about Right to Try

Author: Stacey Johnson, 08/29/17

The crux of Right to Try legislation, enacted by 37 U.S. states so far, is the premise that terminally ill patients should have access to experimental therapies, even if they haven’t been approved by the Food and Drug Administration yet. It sounds straight-forward right? My body, my risk, my decision. The U.S. already has measures…Read more

Valuing the good, the bad and the ugly

Author: David Kent, 08/29/17

As with all of my posts that relate to anything that might end up being a medical treatment, it is important to be very clear that I am scientist and not a physician.  My comments are my own opinion and based on my experience as a stem cell biologist over the last 10+ years. This…Read more

A prescription of hope

Author: Guest, 08/29/17

By Brian Sladek I am honoured to have my blog be just one of several covering this topic as part of Signal’s second annual blog carnival on the theme ‘Right to Try.’ Please click here to read what other bloggers think of this. As a patient, I don’t care about percentages. According to a recent SEER…Read more

An ivory tower perspective of the right-to-try movement: We need to balance the equation

Author: Guest, 08/29/17

Patrick Bedford is the Senior Manager of Clinical Translation and Regulatory Affairs at CCRM. He holds a Master’s Degree in Bioethics and Health Law, and a Regulatory Affairs Certificate. Patrick has spent over 11 years applying federal regulations to emerging biotechnologies in Canada. Follow him on LinkedIN. Do desperate times call for desperate measures in the context…Read more

Right Turn: ‘Right to try’ state of affairs in U.S.

Author: Stacey Johnson, 08/25/17

On Tuesday, August 29, Signals is hosting a blog carnival on the topic Right to Try. Before you read the perspectives of the contributing bloggers, here’s what President Trump thinks about the legislation and the Goldwater Institute’s reaction. It’s the Institute that took on this cause in the first place. Earlier this month, the U.S….Read more

BRM2017: State of the regenerative medicine industry

Author: Stacey Johnson, 08/09/17

Although new to the field of science communication, Nathan Holwell has been involved in a variety of research during his undergraduate career and now in his graduate career. He has done research in drug delivery, gene delivery, biomaterials and diagnostic devices. His graduate research at Queen’s University, where he is pursuing a PhD in Chemical…Read more